Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT00730860
Eligibility Criteria:
Inclusion Criteria:
* patients with hepatocellular,confirmed by pathological examination
* patients with a live function test showed Child A or B
* Indocyanine green test showed less than 30％ after 15min,and the patients showed a tolerance of RFA and TACE
* Tumor stage is early period(according to Milan Standard),that is,the diameter of single node should be less than 5cm；the node of tumor should be less than 3 and the diameter less than 3cm.
* without metastasis in lymphnode or other organs
* written consent inform assigned
Exclusion Criteria:
* preoperative examination showed malignant thrombosis in the first class branch of portal vein or hepatic vein or vena cava
* metastatic cancer of liver
* patients with a poor tolerance of RFA and TACE
* patients received other therapies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00730860
Study Brief:
Protocol Section:
NCT00730860